People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Denali Therapeutics Inc. | — | Biotechnology | Growth/Late | $499.7M | $7.2B | 2024 |
| Apptio Inc | — | Other Technology | Series C | $130.1M | $145.1M | 2018 |
Peter S. Klein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Peter S. Klein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matt McIlwain | 1 | 25 |
| Ravi Mohan | 1 | 14 |
| Rajeev Singh | 1 | 6 |
| Sachin Gupta | 1 | 5 |
| Yuval Scarlat | 1 | 3 |
| Tom Bogan | 1 | 3 |
| MATTHEW S. MCILWAIN | 1 | 3 |
| Thomas Bogan | 1 | 2 |
| Rajeev S. Singh | 1 | 2 |
| Ryan Watts | 1 | 2 |
| Thomas F. Bogan | 1 | 2 |
| Jennifer O. Cook | 1 | 1 |
| Alexander O. Schuth | 1 | 1 |
| JOHN S. MCADAM | 1 | 1 |
| JOHN C. MORROW | 1 | 1 |
| CHRISTOPHER PICK | 1 | 1 |
| RAVI S. MOHAN | 1 | 1 |
| KATHLEEN S. PHILIPS | 1 | 1 |
| LAWRENCE C. BLASKO | 1 | 1 |
| Kurt Shintaffer | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.